Sloan Stuart M's Form 4 filing
Cero Therapeutics Holdings, Inc. (CERO) · filed Nov 20, 2024
- Accession no.
- 0001753926-24-001975
- Filed
- Nov 20, 2024, 4:04 PM ET
- Trade date
- Sep 25, 2024
- Filing delay
- 56 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $55.5K. It was filed 56 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sloan Stuart MCIK 0001215280 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | Common Stock, $0.0001 par value per share | SSaleDisposed | −532,486 | $0.1043F1 | −$55,538.29 | 21,067,956 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades. the price reported above reflects the average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.